Read by QxMD icon Read

Journal of the National Cancer Institute

Johanna M Meulepas, Cécile M Ronckers, Anne M J B Smets, Rutger A J Nievelstein, Patrycja Gradowska, Choonsik Lee, Andreas Jahnen, Marcel van Straten, Marie-Claire Y de Wit, Bernard Zonnenberg, Willemijn M Klein, Johannes H Merks, Otto Visser, Flora E van Leeuwen, Michael Hauptmann
Background: Computed tomography (CT), a strong diagnostic tool, delivers higher radiation doses than most imaging modalities. As CT use has increased rapidly, radiation protection is important, particularly among children. We evaluate leukemia and brain tumor risk following exposure to low-dose ionizing radiation from CT scans in childhood. Methods: For a nationwide retrospective cohort of 168 394 children who received one or more CT scans in a Dutch hospital between 1979 and 2012 who were younger than age 18 years, we obtained cancer incidence, vital status, and confounder information by record linkage with external registries...
July 18, 2018: Journal of the National Cancer Institute
(no author information available yet)
No abstract text is available yet for this article.
July 16, 2018: Journal of the National Cancer Institute
Da-Lin Lu, Charlotte Le Cornet, Disorn Sookthai, Theron S Johnson, Rudolf Kaaks, Renée T Fortner
Background: 27-hydroxycholesterol (27HC) was the first identified endogenous selective estrogen receptor modulator (SERM); 27HC promoted growth and metastasis in experimental models of estrogen receptor-positive mammary cancer. There are no data on prediagnosis circulating 27HC and breast cancer risk in women. Methods: We conducted a nested case-control study in the well-characterized Heidelberg, Germany, cohort of the European Investigation into Cancer and Nutrition (EPIC) including 530 incident invasive breast cancer cases, each matched to up to two control participants (n = 1036)...
July 16, 2018: Journal of the National Cancer Institute
Nikki Burdett, Andrew D Vincent, Michael O'Callaghan, Ganessan Kichenadasse
Background: It is increasingly recognized that older adults with cancer represent a diverse cohort of patients and that other comorbidities may have an equal impact on survival and quality of life as any diagnosis of malignancy. Competing risk has consequently emerged as an important concept in the design and reporting of geriatric oncology trials. Methods: We performed a systematic review of phase II and III oncology trials for systemic therapy in older patients with solid organ malignancy from the year 2000 until April 30, 2017...
July 12, 2018: Journal of the National Cancer Institute
(no author information available yet)
No abstract text is available yet for this article.
July 6, 2018: Journal of the National Cancer Institute
Yibing Yang, Xinya Gao, Maolei Zhang, Nu Zhang
No abstract text is available yet for this article.
July 6, 2018: Journal of the National Cancer Institute
He Chen, Ying Liu, Peiling Li, Daling Zhu
No abstract text is available yet for this article.
July 6, 2018: Journal of the National Cancer Institute
(no author information available yet)
No abstract text is available yet for this article.
July 5, 2018: Journal of the National Cancer Institute
Brittny C Davis Lynn, Philip S Rosenberg, William F Anderson, Gretchen L Gierach
Recent reports of converging black and white breast cancer incidence rates have gained much attention, potentially foreshadowing a worsening of the black-white breast cancer mortality disparity. However, these incidence rates also reflect the sum of non-Hispanics and Hispanics that may mask important ethnicity-specific trends. We therefore assessed race- and ethnicity-specific breast cancer trends using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 13 Registries Database (1992-2014)...
July 5, 2018: Journal of the National Cancer Institute
Samuel O Antwi, Sarah E Fagan, Kari G Chaffee, William R Bamlet, Chunling Hu, Eric C Polley, Steven N Hart, Hermela Shimelis, Jenna Lilyquist, Rohan D Gnanaolivu, Robert R McWilliams, Ann L Oberg, Fergus J Couch, Gloria M Petersen
Background: Increased risk of malignancies other than pancreatic cancer (PC) has been reported among first-degree relatives (FDRs) of PC patients; however, the roles of susceptibility gene mutations are unclear. We assessed risk for 15 cancers among FDRs of unselected PC probands. Methods: Data on 17 162 FDRs, with more than 336 000 person-years at risk, identified through 2305 sequential PC probands enrolled at Mayo Clinic (2000-2016) were analyzed. Family history data were provided by the probands...
July 2, 2018: Journal of the National Cancer Institute
Nicole L Stout, Catherine M Alfano, Christopher W Belter, Ralph Nitkin, Alison Cernich, Karen Lohmann Siegel, Leighton Chan
Cancer rehabilitation research has accelerated as great attention has focused on improving survivorship care. Recent expert consensus has attempted to prioritize research needs and suggests greater focus on studying physical functioning of survivors. However, no analysis of the publication landscape has substantiated these proposed needs. This manuscript provides an analysis of PubMed indexed articles related to cancer rehabilitation published between 1992 and 2017. A total of 22 171 publications were analyzed using machine learning and text analysis to assess publication metrics, topic areas of emphasis, and their interrelationships through topic similarity networks...
June 29, 2018: Journal of the National Cancer Institute
Damir Varešlija, Nolan Priedigkeit, Ailís Fagan, Siobhan Purcell, Nicola Cosgrove, Philip J O'Halloran, Elspeth Ward, Sinéad Cocchiglia, Ryan Hartmaier, Carlos A Castro, Li Zhu, George C Tseng, Peter C Lucas, Shannon L Puhalla, Adam M Brufsky, Ronald L Hamilton, Aju Mathew, Jose P Leone, Ahmed Basudan, Lance Hudson, Róisín Dwyer, Sudipto Das, Darran P O'Connor, Patrick G Buckley, Michael Farrell, Arnold D K Hill, Steffi Oesterreich, Adrian V Lee, Leonie S Young
Background: Breast cancer brain metastases (BrMs) are defined by complex adaptations to both adjuvant treatment regimens and the brain microenvironment. Consequences of these alterations remain poorly understood, as does their potential for clinical targeting. We utilized genome-wide molecular profiling to identify therapeutic targets acquired in metastatic disease. Methods: Gene expression profiling of 21 patient-matched primary breast tumors and their associated brain metastases was performed by TrueSeq RNA-sequencing to determine clinically actionable BrM target genes...
June 28, 2018: Journal of the National Cancer Institute
(no author information available yet)
No abstract text is available yet for this article.
June 28, 2018: Journal of the National Cancer Institute
Nicholas W Fischer, Aaron Prodeus, James Tran, David Malkin, Jean Gariépy
Li-Fraumeni syndrome (LFS) is a rare hereditary cancer disorder with highly variable clinical outcomes that results from germline mutations in the TP53 gene. Here we report that the quaternary structure of p53 is an important factor affecting cellular functions and the clinical outcomes of LFS patients (n = 87). Specifically, carriers of monomeric p53 mutants (n = 56) exhibited complete penetrance, with a 2.11-fold greater risk of cancer-related death (95% confidence interval [CI] = 1.07 to 4.30) and a statistically significantly lower median survival age as compared with carriers of multimeric (dimeric or tetrameric, n = 31) p53 mutants (33 years, 95% CI = 30 to 50, vs 51 years, 95% CI = 40 to NA, respectively, two-sided P = ...
June 27, 2018: Journal of the National Cancer Institute
Khatri Latha, Jun Yan, Yuhui Yang, Loyola V Gressot, Ling-Yuan Kong, Ganiraju Manyam, Ravesanker Ezhilarasan, Qianghu Wang, Erik P Sulman, R Eric Davis, Suyun Huang, Gregory N Fuller, Arvind Rao, Amy B Heimberger, Shulin Li, Ganesh Rao
Background: Virtually all low-grade gliomas (LGGs) will progress to high-grade gliomas (HGGs), including glioblastoma, the most common malignant primary brain tumor in adults. A key regulator of immunosuppression, fibrinogen-like protein 2 (FGL2), may play an important role in the malignant transformation of LGG to HGG. We sought to determine the mechanism of FGL2 on tumor progression and to show that inhibiting FGL2 expression had a therapeutic effect. Methods: We analyzed human gliomas that had progressed from low- to high-grade for FGL2 expression...
June 26, 2018: Journal of the National Cancer Institute
Miguel R Ossandon, Lokesh Agrawal, Eric J Bernhard, Barbara A Conley, Sumana M Dey, Rao L Divi, Ping Guan, Tracy G Lively, Tawnya C McKee, Brian S Sorg, James V Tricoli
The importance of circulating free DNA (cfDNA) in cancer clinical research was recognized in 1994 when a mutated RAS gene fragment was detected in a patient's blood sample. Up to 1% of the total circulating DNA in patients with cancer is circulating tumor DNA (ctDNA) that originates from tumor cells. As ctDNA is rapidly cleared from the blood stream and can be obtained by minimally invasive methods, it can be used as a dynamic cancer biomarker for cancer early detection, diagnosis, and treatment monitoring...
June 20, 2018: Journal of the National Cancer Institute
Veronica Wendy Setiawan, Daniel O Stram, Jacqueline Porcel, Suresh T Chari, Gertraud Maskarinec, Loïc Le Marchand, Lynne R Wilkens, Christopher A Haiman, Stephen J Pandol, Kristine R Monroe
Background: Diabetes has been proposed to be a risk factor for and a consequence of pancreatic cancer (PC). The relationship between recent-onset diabetes and PC is not well understood, and data in minorities are sparse. We examined the relationships between recent-onset diabetes and PC incidence in African Americans and Latinos in the Multiethnic Cohort. Methods: A total of 48 995 African Americans and Latinos without prior diabetes and cancer at baseline (1993-1996) were included in the study...
June 18, 2018: Journal of the National Cancer Institute
Harvey A Risch
No abstract text is available yet for this article.
June 18, 2018: Journal of the National Cancer Institute
Stephanie L Schmit, Christopher K Edlund, Fredrick R Schumacher, Jian Gong, Tabitha A Harrison, Jeroen R Huyghe, Chenxu Qu, Marilena Melas, David J Van Den Berg, Hansong Wang, Stephanie Tring, Sarah J Plummer, Demetrius Albanes, M Henar Alonso, Christopher I Amos, Kristen Anton, Aaron K Aragaki, Volker Arndt, Elizabeth L Barry, Sonja I Berndt, Stéphane Bezieau, Stephanie Bien, Amanda Bloomer, Juergen Boehm, Marie-Christine Boutron-Ruault, Hermann Brenner, Stefanie Brezina, Daniel D Buchanan, Katja Butterbach, Bette J Caan, Peter T Campbell, Christopher S Carlson, Jose E Castelao, Andrew T Chan, Jenny Chang-Claude, Stephen J Chanock, Iona Cheng, Ya-Wen Cheng, Lee Soo Chin, James M Church, Timothy Church, Gerhard A Coetzee, Michelle Cotterchio, Marcia Cruz Correa, Keith R Curtis, David Duggan, Douglas F Easton, Dallas English, Edith J M Feskens, Rocky Fischer, Liesel M FitzGerald, Barbara K Fortini, Lars G Fritsche, Charles S Fuchs, Manuela Gago-Dominguez, Manish Gala, Steven J Gallinger, W James Gauderman, Graham G Giles, Edward L Giovannucci, Stephanie M Gogarten, Clicerio Gonzalez-Villalpando, Elena M Gonzalez-Villalpando, William M Grady, Joel K Greenson, Andrea Gsur, Marc Gunter, Christopher A Haiman, Jochen Hampe, Sophia Harlid, John F Harju, Richard B Hayes, Philipp Hofer, Michael Hoffmeister, John L Hopper, Shu-Chen Huang, Jose Maria Huerta, Thomas J Hudson, David J Hunter, Gregory E Idos, Motoki Iwasaki, Rebecca D Jackson, Eric J Jacobs, Sun Ha Jee, Mark A Jenkins, Wei-Hua Jia, Shuo Jiao, Amit D Joshi, Laurence N Kolonel, Suminori Kono, Charles Kooperberg, Vittorio Krogh, Tilman Kuehn, Sébastien Küry, Andrea LaCroix, Cecelia A Laurie, Flavio Lejbkowicz, Mathieu Lemire, Heinz-Josef Lenz, David Levine, Christopher I Li, Li Li, Wolfgang Lieb, Yi Lin, Noralane M Lindor, Yun-Ru Liu, Fotios Loupakis, Yingchang Lu, Frank Luh, Jing Ma, Christoph Mancao, Frank J Manion, Sanford D Markowitz, Vicente Martin, Koichi Matsuda, Keitaro Matsuo, Kevin J McDonnell, Caroline E McNeil, Roger Milne, Antonio J Molina, Bhramar Mukherjee, Neil Murphy, Polly A Newcomb, Kenneth Offit, Hanane Omichessan, Domenico Palli, Jesus P Paredes Cotoré, Julyann Pérez-Mayoral, Paul D Pharoah, John D Potter, Conghui Qu, Leon Raskin, Gad Rennert, Hedy S Rennert, Bridget M Riggs, Clemens Schafmayer, Robert E Schoen, Thomas A Sellers, Daniela Seminara, Gianluca Severi, Wei Shi, David Shibata, Xiao-Ou Shu, Erin M Siegel, Martha L Slattery, Melissa Southey, Zsofia K Stadler, Mariana C Stern, Sebastian Stintzing, Darin Taverna, Stephen N Thibodeau, Duncan C Thomas, Antonia Trichopoulou, Shoichiro Tsugane, Cornelia M Ulrich, Franzel J B van Duijnhoven, Bethany van Guelpan, Joseph Vijai, Jarmo Virtamo, Stephanie J Weinstein, Emily White, Aung Ko Win, Alicja Wolk, Michael Woods, Anna H Wu, Kana Wu, Yong-Bing Xiang, Yun Yen, Brent W Zanke, Yi-Xin Zeng, Ben Zhang, Niha Zubair, Sun-Seog Kweon, Jane C Figueiredo, Wei Zheng, Loic Le Marchand, Annika Lindblom, Victor Moreno, Ulrike Peters, Graham Casey, Li Hsu, David V Conti, Stephen B Gruber
Background: Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk. Methods: We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315)...
June 16, 2018: Journal of the National Cancer Institute
Michael Lattanzi, Yesung Lee, Danny Simpson, Una Moran, Farbod Darvishian, Randie H Kim, Eva Hernando, David Polsky, Doug Hanniford, Richard Shapiro, Russell Berman, Anna C Pavlick, Melissa A Wilson, Tomas Kirchhoff, Jeffrey S Weber, Judy Zhong, Iman Osman
Background: Two primary histologic subtypes, superficial spreading melanoma (SSM) and nodular melanoma (NM), comprise the majority of all cutaneous melanomas. NM is associated with worse outcomes, which have been attributed to increased thickness at presentation, and it is widely expected that NM and SSM would exhibit similar behavior once metastasized. Herein, we tested the hypothesis that primary histologic subtype is an independent predictor of survival and may impact response to treatment in the metastatic setting...
June 15, 2018: Journal of the National Cancer Institute
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"